China Biologic Products

China Biologic Products (CBPO US)

Health CareUnited States
China Biologic Products Holdings, Inc. operates as a biopharmaceutical company. The Company researches, develops, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. China Biologic Products also distributes pharmaceutical products. China Biologic Products serves clients in China.
bullishiClick Interactive Asia Group27 Sep 2021 17:00

IClick(ICLK US): PAG & Oasis Shake The Trees

Buying around here is probably going to have limited downside. I think PAG/Oasis' intent is to shake out potential suitors - including the co...

bullishNew Frontier Health Corp06 Aug 2021 13:06

New Frontier (NYSE: NFH): Healthcare Homecoming

I see the gross/annualised spread at 7.4%/19.8%, assuming late December completion.  This looks like a pretty clean deal for around five months of...

bullishThematic (Sector/Industry)18 Jul 2021 09:05

China Healthcare Weekly (July.16)

The article mainly analyzed China's plan to accelerate the construction of plasma stations, promising outlook of medical IT industry...

bullish51 Job Inc Adr22 Jun 2021 15:58

51job’s Privatisation: Firm Offer Is Still The Wrong Price

I'd buy here. Given recent Cayman petitions, I would expect this pushback on pricing to continue here, which may avail smaller investors the...

bullish51 Job Inc Adr05 May 2021 09:53

51job's Buyout: Offer Price Unchanged In Updated Proposal

Trading at a gross spread of 15.9%.  With a seasoned player such as Ocean Link now in the mix, plus the CEO, a definitive agreement looks more...